You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 5月10日港股盤前

根據uSMART輿情監測數據,從9日晚間到10日港股盤前時間段,市場關注指數最高的5只股票是比亞迪股份、騰訊控股、吉利汽車、華潤醫藥、匯豐控股。

5月10日—港股關注排行TOP5

輿情變化榜單

比亞迪股份

個股K線圖

關注度第一爲比亞迪股份,該股上個交易日收盤下跌4.11%,報於228.60港元。近5個交易日累計上漲0.62%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

比亞迪長沙工廠廢氣排放疑致多名兒童流鼻血 傳工廠已停產整頓、未知會否影響交付

藍籌股比亞迪ADR瀉9% 港股關注港匯弱勢

騰訊控股

個股K線圖

關注度第二爲騰訊控股,該股上個交易日收盤下跌4.69%,報於349.20港元。近5個交易日累計上漲2.77%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

Hedgeye建議投資者做多京東、做空騰訊

在馬斯克治理下,推特可能成爲“美國版”騰訊?

吉利汽車

個股K線圖

關注度第三爲吉利汽車,該股上個交易日收盤下跌6.60%,報於11.60港元。近5個交易日累計下跌3.97%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

吉利汽車附屬公司擬約13.76億元增持Renault Korea Motors合共4537.5萬股

吉利逾13.7億人幣購南韓汽車銷售商34%股權

華潤醫藥

個股K線圖

關注度第四爲華潤醫藥,該股上個交易日收盤下跌2.61%,報於4.10港元。近5個交易日累計下跌1.44%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

華潤醫藥:華潤三九擬29.02億元收購昆藥28%權益

華潤醫藥:華潤雙鶴已於近期與真實生物訂立爲期十年的戰略合作協議

匯豐控股

個股K線圖

關注度第五爲匯豐控股,該股上個交易日收盤下跌2.87%,報於49.00港元。近5個交易日累計上漲0.31%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

匯控上週五及昨日於倫敦回購逾316萬股 涉1,586萬英鎊

匯豐控股5月6日耗資808.41萬英鎊回購160萬股

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account